China SXT Pharmaceuticals Inc (SXTC)

NASDAQ
Valores en USD
0.3967
+0.0016(+0.00%)
Mercado cerrado
Después del cierre
0.3820-0.0147(-3.7056%)

Cuenta de resultados SXTC

Estado de resultados avanzado
Periodo que termina:
2016
31/03
2017
31/03
2018
31/03
2019
31/03
2020
31/03
2021
31/03
2022
31/03
2023
31/03
2024
31/03
Ingresos totales
aa.aaaa.aaaa.aaaa.aaaa.aa4.782.61.971.93
Crecimiento de los ingresos totales
aa.aaaa.aaaa.aaaa.aaaa.aa-7.45%-45.53%-24.23%-2.19%
Costo de ventas
aa.aaaa.aaaa.aaaa.aaaa.aa1.941.351.551.37
Utilidad bruta
aa.aaaa.aaaa.aaaa.aaaa.aa2.841.250.430.55
Aumento de la utilidad bruta
aa.aaaa.aaaa.aaaa.aaaa.aa+5.02%-55.92%-65.94%+29.96%
Margen de la utilidad bruta
aa.aaaa.aaaa.aaaa.aaaa.aa59.43%48.1%21.62%28.73%
Otros gastos operativos, total
aa.aaaa.aaaa.aaaa.aaaa.aa5.046.445.682.65
Otros gastos operativos, crecimiento total
Gastos de I+D
Gastos de venta, generales y administrativos
Otros gastos operativos
Utilidad de operación
aa.aaaa.aaaa.aaaa.aaaa.aa-2.2-5.19-5.26-2.09
Crecimiento de ingresos operativos
aa.aaaa.aaaa.aaaa.aaaa.aa-63.82%-136.21%-1.32%+60.21%
Margen EBIT %
aa.aaaa.aaaa.aaaa.aaaa.aa-45.99%-199.43%-266.68%-108.49%
Gastos netos por intereses
aa.aaaa.aaaa.aaaa.aaaa.aa-1.11-0.04-0.48-0.54
Crecimiento de gastos netos por intereses
aa.aaaa.aaaa.aaaa.aaaa.aa+66.96%+96.68%-1,199.29%-14.16%
Gastos de intereses, total
aa.aaaa.aaaa.aaaa.aaaa.aa-1.12-0.04-0.48-0.55
Ingresos por intereses e inversiones
aa.aaaa.aaaa.aaaa.aaaa.aa0.010-0.01
Otros gastos no operativos, total
aa.aaaa.aaaa.aaaa.aaaa.aa0.36-0.180.15-0.04
EBT excepto elementos no habituales
aa.aaaa.aaaa.aaaa.aaaa.aa-2.94-5.41-5.59-2.68
Ganancia (pérdida) de la venta de activos
aa.aaaa.aaaa.aaaa.aaaa.aa----
Otras partidas no habituales, total
aa.aaaa.aaaa.aaaa.aaaa.aa---0.35-0.42
EBT, incluyendo partidas inusuales
aa.aaaa.aaaa.aaaa.aaaa.aa-2.94-5.41-5.93-3.1
Crecimiento del EBT, incluidas partidas inusuales
aa.aaaa.aaaa.aaaa.aaaa.aa+71.69%-83.89%-9.74%+47.79%
Margen del EBT, incluidas partidas inusuales
aa.aaaa.aaaa.aaaa.aaaa.aa-61.56%-207.82%-301%-160.67%
Impuesto a la utilidad
aa.aaaa.aaaa.aaaa.aaaa.aa-0.190.33--
Ingresos netos para la empresa
aa.aaaa.aaaa.aaaa.aaaa.aa-2.75-5.74-5.93-3.1
Intereses minoritarios
aa.aaaa.aaaa.aaaa.aaaa.aa----
Ingresos netos
aa.aaaa.aaaa.aaaa.aaaa.aa-2.75-5.74-5.93-3.1
Crecimiento de ingresos netos
aa.aaaa.aaaa.aaaa.aaaa.aa+73.29%-108.72%-3.46%+47.79%
Margen de ingresos netos %
aa.aaaa.aaaa.aaaa.aaaa.aa-57.52%-220.43%-301%-160.67%
Dividendo preferente y otros ajustes
aa.aaaa.aaaa.aaaa.aaaa.aa----
Ingresos netos partidas adicionales sin comunes
aa.aaaa.aaaa.aaaa.aaaa.aa-2.75-5.74-5.93-3.1
BPA básico: Ingresos de actividades continuas
aa.aaaa.aaaa.aaaa.aaaa.aa-95.48-137.92-22.23-3.57
BPA básico: crecimiento de actividades continuas
aa.aaaa.aaaa.aaaa.aaaa.aa+88.52%-44.44%+83.88%+83.93%
BPA diluido: actividades continuas
aa.aaaa.aaaa.aaaa.aaaa.aa-95.48-137.92-22.23-3.57
BPA diluido: crecimiento de actividades continuas
aa.aaaa.aaaa.aaaa.aaaa.aa+88.52%-44.44%+83.88%+83.93%
Promedio ponderado de acciones en circulación básico
aa.aaaa.aaaa.aaaa.aaaa.aa0.030.040.270.87
Promedio ponderado de acciones en circulación diluido
aa.aaaa.aaaa.aaaa.aaaa.aa0.030.040.270.87
Dividendo por acción
aa.aaaa.aaaa.aaaa.aaaa.aa----
Crecimiento del dividendo por acción
aa.aaaa.aaaa.aaaa.aaaa.aa----
EBITDA
aa.aaaa.aaaa.aaaa.aaaa.aa-1.85-4.87-5.01-1.89
Crecimiento del EBITDA
aa.aaaa.aaaa.aaaa.aaaa.aa-83.46%-162.99%-2.84%+62.28%
Margen EBITDA %
aa.aaaa.aaaa.aaaa.aaaa.aa-38.76%-187.13%-253.99%-97.95%
EBIT
aa.aa